North America Idiopathic Thrombocytopenic Purpura Therapeutics Market Size & Outlook

Name: North America Idiopathic Thrombocytopenic Purpura Therapeutics Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The idiopathic thrombocytopenic purpura therapeutics market in North America is expected to reach a projected revenue of US$ 349.7 million by 2030. A compound annual growth rate of 4.5% is expected of North America idiopathic thrombocytopenic purpura therapeutics market from 2024 to 2030.

Pharmaceuticals
- Blood Disorders Treatment
  - idiopathic thrombocytopenic purpura itp therapeutics

North America idiopathic thrombocytopenic purpura itp therapeutics disease type outlook (Revenue, USD million, 2018-2030)
- Acute ITP
- Chronic
- Others
North America idiopathic thrombocytopenic purpura itp therapeutics product outlook (Revenue, USD million, 2018-2030)
- Corticosteroids
- IVIG
- Anti-D Immunoglobulins
- TPO-RA
- Others

North America Idiopathic Thrombocytopenic Purpura Therapeutics Market Size & Outlook

Data Tree

Sign up - it's easy, and free!